Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve DOBUTAMINE HYDROCHLORIDE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve NIVOLUMAB

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve CLOZAPINE

Comment Full text

BIONPHARMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve BEXAROTENE

Comment Full text

HIKMA PHARMS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 40
  • 0 comments

FDA approve LETROZOLE

Comment Full text

NANG KUANG PHARM CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve PEMETREXED DISODIUM

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve EXENATIDE SYNTHETIC

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve IVERMECTIN

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve IVERMECTIN

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 45
  • 0 comments

FDA approve EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 515
  • 516
  • 517
  • 518
  • 519
  • Next

Search

News categories

  • Technical Exchange News(13043)
  • Event(6229)
  • SEC News(322739)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181792)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin